Several studies connect specific VMAT1 variants to psychiatric disorders7,10–12 while VMAT2 function has been connected to PD development, as a larger reduction in VMAT2 activity compared with the reduction of dopaminergic neuronal markers has been measured in samples from PD-patients13. This evidence concerns the gene SLC18A2 and Parkinson disease.